Bio-Path Holdings

$6.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.40 (-5.83%) Today
-$0.20 (-3.10%) As of 1:41 PM UTC after-hours

Why Robinhood?

You can buy or sell BPTH and other stocks, options, and ETFs commission-free!

About BPTH

Bio-Path Holdings, Inc. Common Stock, also called Bio-Path Holdings, is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX. The listed name for BPTH is Bio-Path Holdings, Inc. Common Stock.

CEO
Peter H. Nielsen
Employees
9
Headquarters
Bellaire, Texas
Founded
2007
Market Cap
46.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
11.31M
High Today
$7.03
Low Today
$6.41
Open Price
$6.87
Volume
484.57K
52 Week High
$24.34
52 Week Low
$2.92

BPTH Earnings

-$0.96
-$0.64
-$0.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

VVI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure